Immune to Cancer: The CRI Blog
-
5 Reasons to Give to CRI Before Year’s End
It is a busy time of year dotted with holidays as 2023 comes to a close. At… -
Exploring the Different Types of Cancer and Treatment Options
Cancer is a formidable adversary, but our understanding of this disease has come a long way. Cancer… -
Unraveling the Pro-Tumorigenic Myelopoiesis Driven by an IL-4 Signaling Axis in Bone Marrow
CRI is delighted to share the latest milestone achievement from CRI-supported investigators at Icahn School of Medicine… -
CRI Immunologists Are Armed Against Lung Cancer, the Most Common Cancer Worldwide
A Large Cancer Presence on a Global Scale The Cancer Research Institute (CRI) has a singular focus:… -
How CRI is Taking on Pancreatic Cancer, “The Silent Killer”
Immunotherapy holds the greatest promise for optimizing outcomes for cancer patients, and eventually finding a cure for… -
How to Help CRI Raise Money for Crucial Cancer Immunotherapy Research This Giving Tuesday
“GivingTuesday is an opportunity for people around the world to use their individual power of generosity to… -
CRI Hosts 2023 Annual Awards Dinner, Bestows Coley and Alt Awards on Immunotherapy Giants
NEW YORK — On November 6, 2023, the Cancer Research Institute (CRI) hosted its 2023 Annual Awards… -
3 Runners on Why They are Fundraising for a Future Immune to Cancer with Team CRI at the TCS New York City Marathon
There are a variety of great ways to fundraise on behalf of the Cancer Research Institute (CRI),… -
This is How CRI Funded Scientists are Fighting Breast Cancer
A Global Challenge Breast cancer poses a formidable challenge to healthcare, being one of the most common…